期刊文献+

高原地区肺动脉高压的相关危险因素分析 被引量:4

Analysis of risk factors for pulmonary arterial hypertension in high-altitude areas
下载PDF
导出
摘要 目的:探讨高原地区肺动脉高压(PAH)的相关危险因素。方法:选取符合纳入标准的359例患者作为研究对象,收集患者的一般临床资料及相关实验室检查,进行彩色多普勒超声检查,以肺动脉收缩压(PASP)≥36 mmHg(1 mmHg=0.133 kPa)为界值,分为肺动脉高压组(PAH组,286例)和无肺动脉高压组(对照组,73例)。分析和肺动脉高压有关的指标,以PASP作为因变量,以低密度脂蛋白、血尿酸、血肌酐、血小板、主肺动脉内径作为协变量,进行多因素Logistic回归分析。结果:两组血尿酸、血肌酐、尿素氮、右室舒张末前后径、主肺动脉内径、血小板、血小板压积、低密度脂蛋白比较,差异具有统计学意义(t=-0.63、-8.98、-6.65、-6.56、-2.25、3.18、2.06、2.34,均P<0.05)。PASP与血尿酸、血肌酐、右室前后径、主肺动脉内径均呈正相关(r=0.29、0.20、0.31、0.42,均P<0.05),与低密度脂蛋白、血小板均呈负相关(r=-0.22、-0.13,均P<0.05)。多因素Logistic回归分析显示,血肌酐为肺动脉高压的危险因素(OR=1.044,95%CI:1.019~1.069,P<0.05)。结论:低密度脂蛋白、血小板、血尿酸、血肌酐、右室前后径、主肺动脉内径与高原地区肺动脉高压具有相关性,血肌酐升高为高原地区肺动脉高压的危险因素。 Objective:To explore the possible risk factors associated with pulmonary arterial hypertension(PAH)in high altitude areas.Methods:359 cases of patients who met the inclusion criteria were selected as the research object.The patients′general clinical data and related laboratory tests were collected,and color doppler ultrasound was examined.According to the pulmonary artery systolic pressure PASP≥36 mmHg(1 mmHg=0.133 kPa),the patients were divided into PAH group(286 cases)and non-pulmonary arterial hypertension group(control group,73 cases).Indexes related to PAH were analyzed.Pulmonary systolic blood pressure(PASP)was taken as the dependent variable,and LDL,uric acid,creatinine,platelet,and inner diameter of the main pulmonary artery were taken as the covariates for multivariate Logistic regression analysis.Results:The differences in uric acid,creatinine,urea nitrogen,right ventricular end-diastolic anteroposterior diameter,main pulmonary artery diameter,platelet,platelet deposition,LDL centralized tendency were statistically significant between the two groups(t=-0.63,-8.98,-6.65,-6.56,-2.25,3.18,2.06,2.34,all P<0.05).The PASP was positively correlated with serum uric acid,serum creatinine,anterior and posterior diameter of right ventricle(r=0.29,0.20,0.31,0.42,all P<0.05)and PASP was both negatively with low density lipoprotein,platelet(r=-0.22,-0.13,all P<0.05)in patients.Multivariate Logistic regression analysis showed that serum creatinine were independent risk factors for PAH(OR=1.044,95%CI:1.019-1.069,P<0.05).Conclusion:The LDL,platelet,uric acid,serum creatinine,anterior and posterior diameter of right ventricle are associated with PAH in high altitude areas.Increased serum creatinine is a predictor of PAH in high altitude areas.
作者 刘丽美 李宝娟 魏丽萍 LIU Li-mei;LI Bao-juan;WEI Li-ping(Graduate School,Tianjin Medical University,Tianjin 300070,China;Department of Internal Medicine,Gannan Tibetan Autonomous Prefecture People′s Hospital,Gannan Tibetan Autonomous Prefecture 747000,China;Department of Cardiology,Tianjin Union Medical Center,Tianjin 300121,China)
出处 《天津医科大学学报》 2021年第1期32-35,共4页 Journal of Tianjin Medical University
基金 天津市科委慢病重大专项(16ZXMJSY00060) 天津市人民医院院级课题(2019YJZD001) 京津冀基础研究合作专项(19JCZDJC63900)。
关键词 高原 肺动脉高压 血肌酐 high-altitude pulmonary arterial hypertension serum creatinine
  • 相关文献

参考文献7

二级参考文献48

  • 1Bady E,Achkar A,Pascal S,et al.Pulmonary arterial hypertension in patients with sleep apnoea syndrome[J].Thorax,2000,55(11):934-939.
  • 2Sajkov D,Wang T,Saunders NA,et al.Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease[J].Am J Respir Crit Care Med,1999,159(5 Pt 1):1518-1526.
  • 3Podszns T,Greenberg H,Scharf S.Influence of sleep state and sleep disordered breathing on cardiovascular function.In:Saunders NA,Sullivan CE,eds.Sleep and Breathing[M].New York:Marcel Decker,1994.257-310.
  • 4Guidry UC,Mendes LA,Evans JC,et al.Echoeardiographie features of the right heart in sleep-disordered breathing:the Framingham Heart Study[J].Am J Respir Crit Care Med,2001,164 (6):933-938.
  • 5Duchna HW,Hauptmeier B,Orth M,et al.Daytime ventilatory efficiency in obstructive sleep apnea syndrome--influence of CPAP-therapy[J].Pneumologie,2007,61(8):509-516.
  • 6Steiropoulos P,Tsara V,Nena E,et al.Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome[J].Chest,2007,132(3):843-851.
  • 7Boysen PG,Block AJ,Wynne JW,et al.Nocturnal pulmonary hypertension in patients with chronic obstructive pulmonary disease[J].Chest,1979,76 (5):536-542.
  • 8Mehta S,Hill NS.Noninvasive ventilation[J].Am J Respir Crit Care Med,2001,163(2):540-577.
  • 9Chaouat A,Weitzenblum E,Kessler R,et al.Fiveyear effects of nasal continuous positive airway pressure in obstructive sleep apnoes syndrome[J].Eur Respir J,1997,10(11):2578-2582.
  • 10Dernaika TA,Beavin M,Kinasewitz GT.Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease[J].Respiration,2010,79(5):377-382.

共引文献64

同被引文献47

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部